Search Result "atherogenic modification"
Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2892-2901
Author(s): S. Oravec,A. Dukat,P. Gavornik,M. Kucera,K. Gruber,L. Gaspar,M. Rizzo,P.P. Toth,D.P. Mikhailidis,M. Banach
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov
Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 932-936
Author(s): Nikita G. Nikifirov,Emile R. Zakiev,Natalia V. Elizova,Vasily N. Sukhorukov,Alexander N. Orekhov
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati
Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands
Journal: Current Cardiology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 89-102
Author(s): Julie Nigro, Mandy L. Ballinger, Narin Osman, Anthony M. Dart, Peter J. Little
Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 8-15
Author(s): Takao Kimura, Koichi Sato, Hideaki Tomura, Fumikazu Okajima
The Role of Statins in Oxidative Stress and Cardiovascular Disease
Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 5 Issue: 2 Year: 2005 Page: 165-175
Author(s): Dominic S. Ng
Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 12 Year: 2021 Page: 2438-2450
Author(s): Igor A. Sobenin,Alexander M. Markin,Victor Y. Glanz,Yuliya V. Markina,Wei-Kai Wu,Veronika A. Myasoedova,Alexander N. Orekhov
Epigenetic Modification in Macrophages: A Promising Target for Tumor and Inflammation-associated Disease Therapy
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 15 Year: 2019 Page: 1350-1362
Author(s): Pei Sun,Shu-Jing Zhang,Semenov Maksim,Yong-Fang Yao,Hong-Min Liu,Juan Du